Lab Notes: Chimeron's Covid-19 vaccine candidate shows promise; Lannett gets 2nd NYSE delisting notice By: Philadelphia Business Journal via Business Journals March 25, 2022 at 13:09 PM EDT Recro Pharma has adopted a new name following a major acquisition. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
